ESMO 2023 pancreatic cancer guidelines signal stepwise progress
Hepatobiliary Surg Nutr
.
2024 Apr 3;13(2):362-365.
doi: 10.21037/hbsn-24-37.
Epub 2024 Mar 27.
Authors
Christoph Springfeld
1
,
Peter Bailey
2
,
Markus W Büchler
3
,
John P Neoptolemos
3
Affiliations
1
Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
2
Division of Applied Bioinformatics, The German Cancer Research Center (DKFZ), Heidelberg, Germany.
3
Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
PMID:
38617485
PMCID:
PMC11007323
DOI:
10.21037/hbsn-24-37
No abstract available
Keywords:
Resectable; adjuvant; borderline; neoadjuvant; persister cells.
Publication types
Editorial
Comment